Mifepristone dose in the regimen with misoprostol for medical abortion

Contraception

Volumn 74, Issue 1, 2006, Pages 21-25

  Marions, Lena ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Abortion; Medical abortion; Mifepristone; Misoprostol; Pregnancy termination

Indexed keywords

GEMEPROST; MIFEPRISTONE; MISOPROSTOL; PROSTAGLANDIN DERIVATIVE; SULPROSTONE;

ABORTION; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFICACY; HUMAN; META ANALYSIS; PREGNANCY TERMINATION; REVIEW; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PREGNANCY;

EID: 33745034293     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.03.017     Document Type: Review

References (40)

1. Egarter C.H., and Husslein P. Biochemistry of myometrial contractility. Baillieres Clin Obstet Gynaecol 6 (1991) 755-769
2. Bygdeman M., Christensen N.J., Green K., Zheng S., and Lundström V. Termination of early pregnancy. Acta Obstet Gynecol Scand Suppl 113 (1983) 125-129
3. Herrmann W., Wyss R., Riondel A., et al. Effet d'un steroide antiprogesterone chez la femme: interruption du cycle menstruel et de la grossesse au debut. CR Acad Sci Paris 294 (1982) 933-938
4. Kovacs L., Sas M., Resch B.A., Ugocsai G., Swahn M.L., Bygdeman M., et al. Termination of very early pregnancy by RU 486 - an antiprogestational compound. Contraception 29 (1984) 399-410
5. Shoupe D., Mishell Jr. D.R., Brenner P.F., and Spitz I.M. Pregnancy termination with a high and medium dosage of RU 486. Contraception 33 (1986) 455-461
6. Couzinet B., Le Strat N., Ulmann A., Baulieu E.E., and Schaison G. Termination of early pregnancy by the progesterone antagonist RU 486 (mifepristone). N Engl J Med 315 (1986) 1565-1570
7. Birgersson L., and Odlind V. The antiprogestational agent RU 486 as an abortifacient in early human pregnancy: a comparison of three dose regimens. Contraception 38 (1988) 391-400
8. Bygdeman M., and Swahn M.L. Progesterone receptor blockage. Effect on uterine contractility in early pregnancy. Contraception 32 (1985) 45-51
9. World Health Organization Task Force on Post-Ovulatory Methods for Fertility Regulation. Pregnancy termination with mifepristone and gemeprost: a multicentre comparison between repeated doses and a single dose of mifepristone. Fertil Steril 56 (1991) 32-40
10. World Health Organization Task Force on Post-Ovulatory Methods for Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomized trial. Br J Obstet Gynaecol 107 (2000) 524-530
11. World Health Organization Task Force on Post-Ovulatory Methods for Fertility Regulation. Medical abortion at 57 to 63 days gestation with a lower dose of mifepristone and gemeprost. A randomized controlled trial. Acta Obstet Gynecol Scand 80 (2001) 447-451
12. Maurice J. WHO suggests lower dose of mifepristone. BMJ 303 (1991) 944
13. Kulier R., Gülmezoglu A.M., Hofmeyr G.J., Cheng L.N., and Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev 2 (2004) [Art.No.:CD002855.DOI:10.1002/14651858.CD002855.pub3]
14. World Health Organization Task Force on Post-Ovulatory Methods for Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 307 (1993) 532-537
15. McKinley C., Thong K.J., and Baird D.T. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod 8 (1993) 1502-1505
16. World Health Organization Task Force on Post-Ovulatory Methods for Fertility Regulation. Lowering the doses of mifepristone and gemeprost for early abortion: a randomised controlled trial. BJOG 108 (2001) 738-742
17. Suhonen S., Heikinheimo O., Tikka M., and Haukkamaa M. The learning curve is rapid in medical termination of pregnancy - first year result from the Helsinki area. Contraception 67 (2003) 223-227
18. Thong K.J., and Baird D.T. Induction of abortion with mifepristone and misoprostol in early pregnancy. Br J Obstet Gynaecol 99 (1992) 1004-1007
19. Baird D.T., Sukcharoen N., and Thong K.J. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion. Hum Reprod 10 (1995) 1521-1527
20. Schaff E., Eisinger S.H., Stadalius L.S., Franks P., Gore B.Z., and Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 59 (1999) 1-6
21. Schaff E.A., Fielding S.L., Eisinger S.H., Stadalius L.S., and Fuller L. Low dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 61 (2000) 41-46
22. Bartley J., Brown A., Elton R., and Baird D.T. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation. Hum Reprod 16 (2001) 2098-2102
23. Ashok P.W., Templeton A., Wagaarachchi P.T., and Flett G.M.M. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. BJOG 109 (2002) 1281-1289
24. World Health Organization Task Force on Post-Ovulatory Methods for Fertility Regulation. Multinational study of three misoprostol regimens after mifepristone for early medical abortion: I. Efficacy. BJOG 110 (2003) 808-818
25. Bartley J., Tong S., Everington D., and Baird D.T. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 62 (2000) 297-303
26. Peyron R., Aubeny E., Targosz V., et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 328 (1993) 1509-1513
27. Spitz I.M., Bardin C.W., Benton L., and Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 338 (1998) 1241-1247
28. Aubeny E., and Chatellier G. A randomized comparison of mifepristone and self-administered oral or vaginal misoprostol for early abortion. Eur J Contracept Reprod Health Care 5 (2000) 171-176
29. Aubeny E, Peyron R, Turupin CL, et al. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol. Int J Fertil Menopausal Stud 1995;40(Suppl):85-91, 56.
30. Knudsen U.B. First trimester abortion with mifepristone and vaginal misoprostol. Contraception 63 (2001) 247-250
31. El-Refaey H. Early induction of abortion by a combination of oral mifepristone and misoprostol administered by the vaginal route. Contraception 49 (1994) 111-114
32. El-Refaey H., Rajasekar D., Abdalla M., Calder L., and Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 332 (1995) 983-987
33. Schaff E.A., Stadalius L.S., Eisinger S.H., et al. Vaginal misoprostol administered at home after mifepristone (RU 486) for abortion. J Fam Pract 44 (1997) 353-360
34. Bjorge L., Johnsen S.L., Midboe G., et al. Early pregnancy termination with mifepristone and misoprostol in Norway. Acta Obstet Gynecol Scand 80 (2001) 1056-1061
35. Ulmann A., Silvestre L., Chemama L., Rezvani Y., Renault M., Aguillaume C.J., et al. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Acta Obstet Gynecol Scand 71 (1992) 278-283
36. Swahn M.L., Wang G., Aedo A.R., Cekan S.Z., and Bygdeman M. Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant women. Contraception 34 (1986) 469-481
37. Heikinheimo O., Tevilin M., Shoupe D., Croxatto H., and Lähteenmäki P. Quantitation of RU 486 in human plasma by HPLC and RIA after column chromatography. Contraception 34 (1986) 613-624
38. Heikinheimo O., Lähteenmäki P.L., Koivunen E., Shoupe D., Croxatto H., Luukkainen T., et al. Metabolism and serum binding of RU 486 in women after various single doses. Hum Reprod 2 (1987) 379-385
39. Shi Y.-E., Ye Z.-H., He C.-H., et al. Pharmacokinetic study of RU 486 and its metabolites after oral administration of single doses to pregnant and non-pregnant women. Contraception 48 (1993) 133-149
40. Henshaw S.K., and Finer L.B. The accessibility of abortion services in the United States, 2001. Perspect Sex Reprod Health 35 (2003) 16-24